NOTES_NNS TO_TO THE_DT CONSOLIDATED_JJ FINANCIAL_NNP STATEMENTS_NNS YEAR_VBP ENDED_VBN 31_CD DECEMBER_NNP 1_CD ._.
Segment_NN reporting_NN Segment_NN information_NN is_VBZ presented_VBN in_IN respect_NN of_IN the_DT Groups_NNS business_NN Divisions_NNS ,_, which_WDT are_VBP the_DT primary_JJ basis_NN of_IN segment_NN reporting_NN ._.
The_DT business_NN segment_NN reporting_VBG format_NN reflects_VBZ the_DT Groups_NNS management_NN and_CC internal_JJ reporting_NN structure_NN for_IN 2005_CD including_VBG the_DT effects_NNS of_IN the_DT acquisition_NN of_IN American_JJ Cystoscope_NNP Makers_NNPS Inc._NNP ._.
Inter-segment_JJ pricing_NN is_VBZ determined_VBN on_IN an_DT arms_NNS length_NN basis_NN ._.
Segment_NN results_NNS include_VBP items_NNS directly_RB attributable_JJ to_TO a_DT segment_NN as_RB well_RB as_IN those_DT that_WDT can_MD be_VB allocated_VBN on_IN a_DT reasonable_JJ basis_NN ._.
Business_NNP segments_NNS The_DT Group_NNP is_VBZ comprised_VBN of_IN the_DT following_VBG main_JJ business_NN segments_NNS :_: ENT_NNP Design_NNP ,_, development_NN ,_, manufacture_NN ,_, marketing_NN and_CC sales_NNS of_IN otology_NN ,_, sinus_NN and_CC rhinology_NN and_CC head_NN and_CC neck_NN products_NNS ._.
Surgical_NNP Design_NNP ,_, development_NN ,_, manufacture_NN ,_, marketing_NN and_CC sales_NNS of_IN laparoscopic_JJ surgery_NN products_NNS ._.
Urology_NNP &_CC Gynaecology_NNP Design_NNP ,_, development_NN ,_, marketing_NN and_CC sales_NNS of_IN urology_NN and_CC gynaecology_NN and_CC visualisation_NN products_NNS ._.
It_PRP represents_VBZ the_DT acquired_VBN American_JJ Cystoscope_NNP Makers_NNPS Inc_NNP ACMI_NNP business_NN ._.
Partnered_NNP Technologies_NNPS Out-licensing_NN of_IN the_DT Groups_NNS proprietary_JJ technology_NN in_IN conjunction_NN with_IN a_DT manufacturing_NN contract_NN for_IN markets_NNS outside_IN the_DT Groups_NNS core_NN sales_NNS and_CC marketing_NN competence_NN ._.
From_IN 1_CD January_NNP 2006_CD certain_JJ products_NNS have_VBP been_VBN swapped_VBN between_IN the_DT Surgical_NNP and_CC the_DT Urology_NNP &_CC Gynaecology_NNP Divisions_NNPS ._.
In_IN future_JJ years_NNS segment_NN reporting_NN will_MD be_VB conducted_VBN on_IN this_DT divisional_JJ basis_NN ._.
Partnered_NNP Urology_NNP &_CC ENT_NNP Surgical_NNP Technologies_NNPS Gynaecology_NNP Total_NNP For_IN the_DT year_NN ended_VBD 31_CD December_NNP 2005 000 000 000_CD 000_CD 000_CD Revenue_NN External_NNP Sales_NNS 40,119_CD 37,174_CD 22,652_CD 50,431_CD 150,376_CD Inter-segment_NN sales_NNS 1,715_CD 1,750_CD 1,501_CD 622_CD 5,588_CD 41,834_CD 38,924_CD 24,153_CD 51,053_CD 155,964_CD Segment_NN result_NN before_IN restructuring_VBG charges_NNS 1,946_CD 7,967_CD 4,172_CD 3,863_CD 17,948_CD Restructuring_NN charges_NNS 846_CD 876_CD 34_CD 613_CD 2,369_CD Material_NNP non-recurring_JJ item_NN 4,686_CD 4,686_CD Segment_NN result_NN after_IN restructuring_VBG charges_NNS and_CC material_NN non-recurring_JJ item_NN 1,100_CD 7,091_CD 4,138_CD 1,436_CD 10,893_CD Unallocated_JJ corporate_JJ expenses_NNS 475_CD Profit_NN from_IN operations_NNS 10,418_CD Net_JJ finance_NN costs_NNS excluding_VBG material_NN non-recurring_JJ items_NNS 5,463_CD Material_NNP non-recurring_JJ items_NNS 1,980_CD Profit_NN before_IN tax_NN 6,935_CD Income_NNP tax_NN expense_NN 659_CD Profit_NN for_IN the_DT year_NN 6,276_CD Partnered_NNP Urology_NNP &_CC ENT_NNP Surgical_NNP Technologies_NNPS Gynaecology_NNP Unallocated_NNP Total_NNP 31_CD December_NNP 2005 000 000 000_CD 000 000 000_CD Capital_NN additions_NNS 1,197_CD 1,409_CD 653 921 114_CD 4,294_CD Depreciation_NN 2,221_CD 939 546 555_CD 55_CD 4,316_CD Amortisation_NNP 128_CD 63_CD 32_CD 4,104_CD 4,327_CD Assets_NNS 130,402_CD 45,901_CD 25,835_CD 319,695_CD 5,769_CD 516,064_CD Liabilities_NNPS 59,907_CD 3,910_CD 3,497_CD 145,427_CD 1,818_CD 214,559_CD Gyrus_NNP Group_NNP PLC_NNP Annual_JJ Report_NNP and_CC Accounts_NNPS 2005_CD 54_CD Partnered_NNP Urology_NNP &_CC ENT_NNP Surgical_NNP Technologies_NNPS Gynaecology_NNP Total_NNP For_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004 000 000 000_CD 000_CD 000_CD Revenue_NN External_NNP Sales_NNS 38,369_CD 28,822_CD 19,739_CD 86,930_CD Inter-segment_NN sales_NNS 1,179_CD 1,346_CD 2,525_CD 39,548_CD 30,168_CD 19,739_CD 89,455_CD Segment_NN result_NN 1,764_CD 5,892_CD 3,983_CD 11,639_CD Unallocated_JJ corporate_JJ expenses_NNS 1,564_CD Profit_NN from_IN operations_NNS 10,075_CD Net_JJ finance_NN cost_NN 88_CD Profit_NN before_IN tax_NN 9,987_CD Income_NNP tax_NN expense_NN 1,504_CD Profit_NN for_IN the_DT year_NN 8,483_CD Partnered_NNP Urology_NNP &_CC ENT_NNP Surgical_NNP Technologies_NNPS Gynaecology_NNP Unallocated_NNP Total_NNP 31_CD December_NNP 2004 000 000 000_CD 000 000 000_CD Capital_NN additions_NNS 1,145_CD 927_CD 570_CD 15_CD 2,657_CD Depreciation_NN 2,106792585793,562_CD Amortisation_NNP 85261346_CD Assets_NNPS 98,40938,43217,943_CD 12,000_CD 142,784_CD Liabilities_NNPS 60,981_CD 2,686_CD 2,683_CD 45,219_CD 21,131_CD The_DT average_JJ number_NN of_IN employees_NNS for_IN the_DT year_NN for_IN each_DT of_IN the_DT Groups_NNS principal_JJ Divisions_NNS was_VBD as_IN follows_VBZ :_: Year_NN ended_VBD Year_NN ended_VBD 31_CD December_NNP 2005_CD 31_CD December_NNP 2004_CD ENT_NNP 235_CD 223_CD Surgical_NNP 273_CD 250_CD Partnered_NNP Technologies_NNPS 139_CD 133_CD Urology_NNP &_CC Gynaecology_NNP 819_CD Head_NNP office_NN and_CC administration_NN 32_CD 26_CD 1,498_CD 632_CD Geographical_NNP Segments_NNP Year_NN ended_VBD Year_NN ended_VBD 31_CD December_NNP 2005_CD 31_CD December_NNP 2004_CD Turnover_NN by_IN destination_NN 000_CD 000_CD North_NNP America_NNP 111,361_CD 58,427_CD United_NNP Kingdom_NNP and_CC rest_NN of_IN Europe_NNP 28,196_CD 21,747_CD Rest_VBP of_IN world_NN 10,819_CD 6,756_CD 150,376_CD 86,930_CD 31_CD December_NNP 2005_CD 31_CD December_NNP 2004_CD Assets_NNPS 000_CD 000_CD North_NNP America_NNP 467,545_CD 116,525_CD United_NNP Kingdom_NNP and_CC rest_NN of_IN Europe_NNP 47,234_CD 25,882_CD Rest_VBP of_IN world_NN 1,285_CD 377_CD 516,064_CD 142,784_CD 31_CD December_NNP 2005_CD 31_CD December_NNP 2004_CD Capital_NNP Additions_NNPS 000_CD 000_CD North_NNP America_NNP 3,107_CD 2,005_CD United_NNP Kingdom_NNP and_CC rest_NN of_IN Europe_NNP 1,093_CD 652_CD Rest_VBP of_IN world_NN 94_CD 4,294_CD 2,657_CD Gyrus_NNP Group_NNP PLC_NNP Annual_JJ Report_NNP and_CC Accounts_NNPS 2005_CD 55_CD
